JOHN BELMONT to Recombinant Fusion Proteins
This is a "connection" page, showing publications JOHN BELMONT has written about Recombinant Fusion Proteins.
Connection Strength
0.299
-
Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. Hum Gene Ther. 1997 May 01; 8(7):861-8.
Score: 0.114
-
Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector. Hum Gene Ther. 1991; 2(4):307-15.
Score: 0.074
-
X-linked Menkes disease: first documented report of germ-line mosaicism. Genet Test. 2004; 8(3):286-91.
Score: 0.045
-
In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK. Hum Gene Ther. 1995 Sep; 6(9):1215-23.
Score: 0.025
-
Inhibition of HIV-1 by a double transdominant fusion gene. Gene Ther. 1995 May; 2(3):181-6.
Score: 0.025
-
Expression vectors for human adenosine deaminase gene therapy. Genome. 1989; 31(2):832-9.
Score: 0.016